Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis

Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis

Abstract The expression of the receptor tyrosine kinase Axl and its cleavage product soluble Axl (sAxl) is increased in liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). In this multicenter study, we evaluated the diagnostic value of Gas6, the high-affinity ligand of Axl, in patients wi...

Full description

Bibliographic Details
Main Authors:	Katharina Staufer, Heidemarie Huber, Jasmin Zessner-Spitzenberg, Rudolf Stauber, Armin Finkenstedt, Heike Bantel, Thomas S. Weiss, Markus Huber, Patrick Starlinger, Thomas Gruenberger, Thomas Reiberger, Susanne Sebens, Gail McIntyre, Ray Tabibiazar, Amato Giaccia, Heinz Zoller, Michael Trauner, Wolfgang Mikulits
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-08-01
Series:	Cell Death Discovery
Online Access:	https://doi.org/10.1038/s41420-023-01551-6

Similar Items

Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
by: Gregor Ortmayr, et al.
Published: (2022-03-01)

Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.
by: Stefanie Haegele, et al.
Published: (2015-01-01)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
by: Katharina Staufer, et al.
Published: (2023-07-01)

Mechanisms of cell death in acute liver failure
by: Heike eBantel
Published: (2012-04-01)

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis
by: Thomas Reiberger
Published: (2022-05-01)

Target‐Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model‐Informed Dose Selection for the First‐in‐Human Study of AVB‐S6‐500
by: Laura Bonifacio, et al.
Published: (2020-01-01)

Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
by: David Pereyra, et al.
Published: (2017-01-01)

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.
by: Tobias Meischl, et al.
Published: (2019-01-01)

NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
by: Patricia Sancho, et al.
Published: (2012-01-01)

The Ratio of Activin A and Follistatin-Like 3 Is Associated With Posthepatectomy Liver Failure and Morbidity in Patients Undergoing Liver Resection
by: Jonas Santol, et al.
Published: (2023-01-01)

Liver Transplantation For Alcoholic Liver Disease – Time for a Paradigm Shift?
by: Katharina Staufer, et al.
Published: (2014-05-01)

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
by: Zielinski Christoph, et al.
Published: (2008-04-01)

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?
by: Per Pfeiffer, et al.
Published: (2018-08-01)

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality
by: Lukas Hartl, et al.
Published: (2021-10-01)

Current Treatment Options for Cystic Fibrosis-Related Liver Disease
by: Katharina Staufer
Published: (2020-11-01)

PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells
by: Francesca Virginia Bruschi, et al.
Published: (2019-09-01)

Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer
by: Nataliia Petriv, et al.
Published: (2021-01-01)

Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.
by: Kristin Wahl, et al.
Published: (2012-01-01)

Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate.
by: Timo Weiland, et al.
Published: (2012-01-01)

Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase
by: Ivan Bradić, et al.
Published: (2023-09-01)

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
by: Lorenz Balcar, et al.
Published: (2023-04-01)

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
by: Seidel Christoph, et al.
Published: (2012-05-01)

Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
by: Petra Koudelkova, et al.
Published: (2015-01-01)

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
by: Lorenz Balcar, et al.
Published: (2022-11-01)

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension
by: Oleksandr Petrenko, et al.
Published: (2024-03-01)

Transcriptomic landscapes of effective and failed liver regeneration in humans
by: Patrick Starlinger, et al.
Published: (2023-04-01)

The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
by: Lukas Hartl, et al.
Published: (2023-01-01)

The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
by: Lauritz Miarka, et al.
Published: (2019-05-01)

Tumour suppressors in liver carcinogenesis.
by: Dufour, J, et al.
Published: (2007)

Two-dimensional shear wave elastography (ElastQ) accurately rules out liver fibrosis and rules in advanced chronic liver disease across liver disease etiologies: a prospective multicenter study
by: David J. M. Bauer, et al.
Published: (2023-10-01)

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
by: Bernhard Scheiner, et al.
Published: (2015-01-01)

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma
by: Viola Hedrich, et al.
Published: (2023-04-01)

Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality
by: Lukas Hartl, et al.
Published: (2024-01-01)

Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR
by: Georg Semmler, et al.
Published: (2021-04-01)

PNPLA3 expression and its impact on the liver: current perspectives
by: Bruschi FV, et al.
Published: (2017-11-01)

Till Death Do Us Part—The Multifaceted Role of Platelets in Liver Diseases
by: Marion Mussbacher, et al.
Published: (2021-03-01)

Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
by: Georg Semmler, et al.
Published: (2023-02-01)

Quality of life and psychosocial situation before and after a lung, liver or an allogeneic bone marrow transplant
by: R Wagner-Huber
Published: (2006-05-01)

MicroRNA-125b-5p mimic inhibits acute liver failure
by: Dakai Yang, et al.
Published: (2016-06-01)

Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease.
by: J S Owen, et al.
Published: (1982-01-01)